Maintaining Myocardial Glucose Utilization in Diabetic Cardiomyopathy Accelerates Mitochondrial Dysfunction

Area of Science:

• Cardiovascular Biology
• Metabolic Disease
• Mitochondrial Medicine

Background:

• Diabetic cardiomyopathy is characterized by reduced cardiac glucose uptake and mitochondrial dysfunction, despite hyperglycemia.
• The adaptive or maladaptive nature of these metabolic changes remains unclear.

Purpose of the Study:

• To investigate the direct impact of enhanced cardiomyocyte glucose uptake on mitochondrial function in the context of diabetes and diabetic cardiomyopathy.
• To elucidate the mechanisms by which glucose affects mitochondrial function and gene expression in the diabetic heart.

Main Methods:

• Generation of transgenic mice with inducible cardiomyocyte-specific GLUT4 expression.
• Induction of hyperglycemia using streptozotocin followed by transgene induction to increase glucose uptake.
• Assessment of cardiac function via echocardiography and mitochondrial ATP generation.
• Transcriptomic analysis and investigation of O-GlcNAcylation pathways.

Main Results:

• In nondiabetic mice, increased myocardial glucose uptake reduced mitochondrial ATP generation and caused diastolic dysfunction.
• In diabetic mice, enhanced glucose delivery exacerbated mitochondrial oxidative dysfunction.
• Transcriptomic analysis revealed significant glucose- and diabetes-driven changes in mitochondrial function genes, partly mediated by O-GlcNAcylation of Sp1.
• Increased glucose uptake led to O-GlcNAcylation of mitochondrial proteins, including electron transport chain subunits.

Conclusions:

• Mitochondria are a primary target of glucose toxicity (glucotoxicity) in the heart.
• Reduced cardiac glucose utilization in diabetes may be a protective mechanism against glucotoxicity.
• Restoring cardiac glucose delivery in diabetes could accelerate mitochondrial dysfunction by overriding protective metabolic adaptations.